Related Experiment Video
Updated: Mar 22, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Mortality and complications in 3495 children with isolated ventricular septal defects
Jarle Jortveit1, Elisabeth Leirgul2, Leif Eskedal3
1Department of Cardiology, Sørlandet, Arendal, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Insights
Children with isolated ventricular septal defects (VSDs) have a favorable prognosis, with no increased mortality. Cardiac complications like endocarditis and arrhythmias were infrequent in this congenital heart defect population.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease Epidemiology
Background:
- Ventricular septal defects (VSDs) are the most common congenital heart defects (CHDs).
- Previous research suggested increased risks of endocarditis, aortic regurgitation, outflow tract obstruction, pulmonary hypertension, arrhythmias, and sudden death in isolated VSD patients.
- This study investigates mortality and cardiac complications in children with isolated VSDs.
Purpose of the Study:
- To report mortality and cardiac complications requiring hospitalization or intervention in children with isolated VSDs.
- To assess the long-term prognosis of isolated VSDs in a nationwide cohort.
Main Methods:
- A nationwide cohort study utilizing data from Norwegian registries (Medical Birth Registry, Cardiovascular Disease in Norway, Oslo University Hospital's Clinical Registry of Congenital Heart Defects, Norwegian Cause of Death Registry).
- Inclusion criteria: live births in Norway (1994-2009) without known chromosomal aberrations or extracardiac malformations.
- Follow-up until 2013 to identify mortality and cardiac complications.
Main Results:
- Isolated VSDs were identified in 3495 children.
- Surgical or catheter-based treatment was performed in 5.2% of cases.
- No excess mortality was observed in children with isolated VSDs compared to controls (adjusted HR 0.8).
- Cardiac complications were infrequent: endocarditis (0.9‰), aortic regurgitation (3.4‰), pulmonary hypertension (0.3‰), and arrhythmias (4.6‰). Left ventricular outflow tract obstructions were not recorded.
Conclusions:
- Children with isolated VSDs exhibit a favorable prognosis with no increased overall mortality.
- Cardiac complications requiring hospitalization or intervention, such as endocarditis and arrhythmias, are infrequent during childhood for isolated VSDs.
Background:
Ventricular septal defects (VSDs) are the most common congenital heart defects (CHDs). Previous studies indicate an increased risk of endocarditis, aortic regurgitation, left ventricular outflow tract obstructions, pulmonary hypertension, arrhythmias and sudden death in patients with isolated VSDs. The present nationwide cohort study reports mortality and cardiac complications requiring hospitalisation or intervention in children with isolated VSDs.
Methods And Results:
Medical information concerning all 943 871 live births in Norway in 1994-2009 was retrieved from the Medical Birth Registry of Norway, the Cardiovascular Disease in Norway project, the Oslo University Hospital's Clinical Registry of Congenital Heart Defects and the Norwegian Cause of Death Registry. Isolated VSDs were identified in 3495 children without known chromosomal aberrations or extracardiac malformations. Surgical or catheter-based treatment of VSD was performed in 181 (5.2%) cases. Twelve (0.3%) children with VSDs died before 2013. There was no operative mortality, and no excess mortality in children with isolated VSDs compared with children without VSDs (adjusted HR 0.8 (0.5 to 1.4), p=0.48). The following conditions were recorded as possible cardiac complications of the VSDs: endocarditis in 3 children (0.9‰), aortic regurgitation in 12 children (3.4‰), left ventricular outflow tract obstructions in no children (0.0‰), pulmonary hypertension in 1 child (0.3‰) and arrhythmias in 16 children (4.6‰).
Conclusions:
The entire group of children with isolated VSDs had a favourable prognosis without excess mortality. Cardiac complications requiring hospitalisation or intervention, including endocarditis, aortic regurgitation, left ventricular outflow tract obstructions, pulmonary hypertension and arrhythmias, were infrequent during childhood.
Trial Registration Number:
NCT02026557.
Related Concept Videos
Mitral Stenosis I: Introduction
Pneumonia III: Complications and Assessment
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests

